Constellation Brands (STZ): 100% Mexico Beer, New CEO, Margin Reset — Six Lenses on a Multiple Compression

Constellation Brands manufactures 100% of its beer in Mexico — the most concentrated production geography of any major U.S. beverage company. Modelo Especial is the #1 selling beer in the U.S. by dollars. Corona Extra is the second-largest imported beer. Pacifico, per management, is “exploding” nationally. And the company holds the perpetual exclusive U.S. import sub-license for the Mexican beer brands — a structural moat that AB InBev, Heineken, and Molson Coors cannot replicate.

Yet the multiple has compressed to ~14-15x forward EPS, well below historical premium-beverages levels of 18-22x. The dominant bear narrative attaches to four factors: (1) Mexico-tariff exposure, (2) premium beer demand peaking, (3) CEO transition risk as Nicholas Fink takes over from Bill Newlands on April 13, 2026, and (4) capital intensity persisting into demand softness.

The committee's six-lens analysis found something more nuanced: the bear narrative is correctly identifying real risks, but it has anchored on stale tariff probabilities. SCOTUS invalidated the IEEPA-based tariff pathway. April 2026 brought a Section 232 malt-beer carve-out. Q4 FY26 showed sequential depletion improvement in all Hispanic-concentration ZIP code quintiles. None of this changes the structural risk profile — but it materially changes the probability distribution.

The 25% Mexico beer tariff scenario was a credible base case in early 2025. By April 2026, it is a tail scenario rather than a base case. Two material developments:

First, the Supreme Court invalidated the IEEPA-based tariff authority — the most expedient legal pathway for sweeping tariffs. Future tariffs require procedural compliance with Section 232 (national security), Section 301 (unfair trade practices), or Section 122 (balance of payments). Slower, narrower, more challengeable.

Second, in April 2026 the U.S. government removed beer made from malt — which includes STZ's beer products — from the scope of Section 232 aluminum tariffs that had been in place at various rates since February 2025. This is built into the FY 2027 37%-38% beer operating margin guidance. The FY 2026 actual tariff cost was $58.3M, or about 0.6% of revenue. Material but not transformational.

The dominant narrative has not fully updated. The remaining tariff vectors are real — USMCA review (six-year window in 2026), aluminum derivative imports (still in scope), Canadian retaliatory wine and spirits bans (in place), immigration enforcement effects on Hispanic consumer base. But the catastrophic 25% blanket scenario probability has decreased materially.

The fiscal year ending February 28, 2026 produced the first negative beer volume year for STZ in over a decade. Shipments −3.8%, depletions −2.1%, net sales −3%. The bear case framed this as the start of structural deceleration: GLP-1 attenuation, cannabis substitution, anti-alcohol public health momentum, premium-beer cycling down post-COVID.

The Q4 FY 2026 print provided the first incremental positive datapoint:

• Depletions positive in Q4 (vs. negative in three prior quarters)
• All Hispanic-concentration ZIP code quintiles improving sequentially
• California share gain accelerating to 1+ point in last 4 weeks
• Outgoing CEO Newlands: “March is off to a solid start, better than planned with continued increasing momentum”

One quarter of data is not a confirmed trend, and FY 2027 guidance of −2% to +1% beer revenue confirms management does not expect rapid return to growth. But this is the first piece of evidence supporting the cyclical-pause framing rather than structural-deceleration framing. Market response has been muted — the inflection coincided with a margin guide cut, and macro skepticism remains high across CPG generally.

STZ spent $875M on capex in FY 2026 — most of it on the Veracruz brewery, which is scheduled to begin production around the middle of FY 2027. The company also repurchased 5,652,107 shares at an average price of $163.50, for $924.1M aggregate cost. The current price is roughly $145, implying approximately $57M of paper loss on FY 2026 buybacks alone.

The Veracruz construction creates ~$58M+ of fixed cost absorption headwind in FY 2027 — built into the 37%-38% beer margin guide. STZ has missed brewery execution before. The Mexicali Brewery was canceled. The Obregón Brewery took a $109.8M asset impairment in FY 2026. Veracruz is now the third major capacity bet.

Outgoing CEO Newlands acknowledged the flexibility: “some of that spend will get delayed as we bring on capacity later than expected and some of it may get avoided altogether.” But Veracruz itself is past the point of meaningful deferral.

The pattern — building new capacity while buying back stock at prices the market has since fallen below — signals management confidence. It also signals capital allocation stress if FY 2027 produces another negative volume year. Both interpretations are partially correct.

The 10-K Item 1A explicitly flags pledged-share collateral risk:

“The sale by such financial institutions of a substantial amount of the pledged shares could depress, or result in volatility in, the trading price of our Class A Stock.”

The volume of Sands Family pledged shares is undisclosed in current filings. If pledged-share collateral covenants reference market value, a further leg down in the stock could trigger forced selling — a reflexive doom-loop dynamic that compounds with fundamental drawdowns.

This is the most material under-disclosed risk in the STZ profile. Investors cannot precisely size the exposure because the share-pledge volume is opaque. Any 10-Q or proxy disclosure of size or covenant changes would be materially informative.

Black Swan Beacon was triggered based on cross-domain compound risk criteria. The most material compound scenarios: